Your browser doesn't support javascript.
loading
Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
Teschke, Rolf; Méndez-Sánchez, Nahum; Eickhoff, Axel.
Affiliation
  • Teschke R; Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt, 63450 Hanau, Germany.
  • Méndez-Sánchez N; Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City 14050, Mexico.
  • Eickhoff A; Faculty of Medicine, National Autonomous University of Mexico, Mexico City 04510, Mexico.
Int J Mol Sci ; 23(9)2022 Apr 27.
Article in En | MEDLINE | ID: mdl-35563242
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Chemical and Drug Induced Liver Injury / COVID-19 Drug Treatment Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Systematic_reviews Limits: Female / Humans / Male / Middle aged Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiviral Agents / Chemical and Drug Induced Liver Injury / COVID-19 Drug Treatment Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Systematic_reviews Limits: Female / Humans / Male / Middle aged Language: En Journal: Int J Mol Sci Year: 2022 Type: Article Affiliation country: Germany